Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandrajit P Raut

Showing results (181-190 of 229) with videos related to

Pageof 23
Sort By:
Annals of Surgical Oncology|October 19, 2020
Has the Outcome for Patients Who Undergo Resection of Primary Retroperitoneal Sarcoma Changed Over Time? A Study of Time Trends During the Past 15 yearsDario Callegaro, Chandrajit P Raut, Deanna Ng, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2011
Aberrant AKT activation drives well-differentiated liposarcomaAlejandro Gutierrez, Eric L Snyder, Adrian Marino-Enriquez, et al.
The New England Journal of Medicine|April 4, 2014
Thyroid hormone inactivation in gastrointestinal stromal tumorsMichelle A Maynard, Adrian Marino-Enriquez, Jonathan A Fletcher, et al.
The Lancet. Oncology|April 30, 2026
Bayesian sequential learning for prognostication in extremity soft tissue sarcoma (BayeSarc): a retrospective, multicentre cohort studyDario Callegaro, Gabriele Tinè, Sandro Pasquali, et al.
British Journal of Cancer|February 23, 2019
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumoursCésar Serrano, Adrián Mariño-Enríquez, Derrick L Tao, et al.
British Journal of Cancer|May 25, 2019
Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumoursCésar Serrano, Adrián Mariño-Enríquez, Derrick L Tao, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2021
Longitudinal prognostication in retroperitoneal sarcoma survivors: Development and external validation of two dynamic nomogramsDario Callegaro, Francesco Barretta, Carol J Swallow, et al.
Annals of Surgical Oncology|October 28, 2022
Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas: A Systematic Review of the LiteratureEmily Z Keung, Kate J Krause, Jessica Maxwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2015
Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma VaccinesJohn M Goldberg, David E Fisher, George D Demetri, et al.
Cancer|February 27, 2016
External validation of a multi-institutional retroperitoneal sarcoma nomogramChandrajit P Raut, Rosalba Miceli, Dirk C Strauss, et al.
Pageof 23

Showing results (181-190 of 229) with videos related to

Sort By:
Pageof 23
Annals of Surgical Oncology|October 19, 2020
Has the Outcome for Patients Who Undergo Resection of Primary Retroperitoneal Sarcoma Changed Over Time? A Study of Time Trends During the Past 15 yearsDario Callegaro, Chandrajit P Raut, Deanna Ng, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2011
Aberrant AKT activation drives well-differentiated liposarcomaAlejandro Gutierrez, Eric L Snyder, Adrian Marino-Enriquez, et al.
The New England Journal of Medicine|April 4, 2014
Thyroid hormone inactivation in gastrointestinal stromal tumorsMichelle A Maynard, Adrian Marino-Enriquez, Jonathan A Fletcher, et al.
The Lancet. Oncology|April 30, 2026
Bayesian sequential learning for prognostication in extremity soft tissue sarcoma (BayeSarc): a retrospective, multicentre cohort studyDario Callegaro, Gabriele Tinè, Sandro Pasquali, et al.
British Journal of Cancer|February 23, 2019
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumoursCésar Serrano, Adrián Mariño-Enríquez, Derrick L Tao, et al.
British Journal of Cancer|May 25, 2019
Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumoursCésar Serrano, Adrián Mariño-Enríquez, Derrick L Tao, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2021
Longitudinal prognostication in retroperitoneal sarcoma survivors: Development and external validation of two dynamic nomogramsDario Callegaro, Francesco Barretta, Carol J Swallow, et al.
Annals of Surgical Oncology|October 28, 2022
Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas: A Systematic Review of the LiteratureEmily Z Keung, Kate J Krause, Jessica Maxwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2015
Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma VaccinesJohn M Goldberg, David E Fisher, George D Demetri, et al.
Cancer|February 27, 2016
External validation of a multi-institutional retroperitoneal sarcoma nomogramChandrajit P Raut, Rosalba Miceli, Dirk C Strauss, et al.
Pageof 23